Results of Operations and Financial Condition. On August 3, 2026, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended June 30, 2026. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnished here…

Results of Operations and Financial Condition. On April 29, 2026, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended March 31, 2026. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnished her…

Results of Operations and Financial Condition. On February 12, 2026, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended December 31, 2025. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnish…

Chief Investment Officer — Talya Nevo-Hacohen: The filing discloses the planned retirement of the Chief Investment Officer with a named internal successor (Darrin Smith) appointed to take over the role, representing an orderly succession rather than a sudden loss of leadership.

Results of Operations and Financial Condition. On November 5, 2025, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended September 30, 2025. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnish…

Entry into a Material Definitive Agreement. On August 5, 2025, Sabra Health Care REIT, Inc. (the “ Company ”) entered into an equity distribution agreement (the “ Distribution Agreement ”) with Barclays Capital Inc., BMO Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Credit Agricole Securities (USA) Inc., Fifth Third Securities, Inc., Huntington Securities, Inc., J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securi…

Termination of a Material Definitive Agreement. On August 5, 2025, the Company terminated that certain equity distribution agreement entered into on February 23, 2023 among the Company and the sales agents and forward purchasers party thereto (the “ Prior Distribution Agreement ”). The Prior Distribution Agreement provided for the issuance and sale from time to time of shares of Common Stock having an aggregate gross sales price of up to $500.0 million (i) by the Company through a consortium…

Results of Operations and Financial Condition. On August 4, 2025, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended June 30, 2025. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnished here…

Other Events. Interest Rate Swaps On June 27, 2025, Sabra entered into forward starting interest rate swaps with an effective date of July 30, 2025 and an aggregate notional amount of $500.0 million which fix the SOFR portion of the interest rate for SOFR-based borrowings at a weighted average rate of 3.44%. After giving effect to the forward starting interest rate swaps, the effective interest rate for the Term Loan is 4.64% through July 30, 2030. 2026 Notes Redemption As previously disclose…

Entry into a Material Definitive Agreement. On July 30, 2025, Sabra Health Care Limited Partnership, of which Sabra Health Care REIT, Inc. (“Sabra”) is the sole general partner (the “Operating Partnership”), and Sabra Canadian Holdings, LLC, also a wholly owned subsidiary of Sabra (together, the “Borrowers”), together with Sabra and certain subsidiaries of Sabra, as Guarantors, entered into an unsecured credit agreement (the “Term Loan Credit Agreement”) with certain lenders as set forth ther…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure in

Other Events. On June 30, 2025, Sabra Health Care REIT, Inc. (the “Company”) announced that its subsidiary, Sabra Health Care Limited Partnership (the “Limited Partnership”), will redeem all $500 million aggregate principal amount of its outstanding 5.125% Senior Notes due 2026 (the “Notes”) on July 31, 2025 (the “Redemption Date”). On the Redemption Date, in accordance with the terms of the Notes, and the indenture and supplemental indentures governing the Notes (collectively, the “Indenture…

Results of Operations and Financial Condition. On May 5, 2025, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended March 31, 2025. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnished herewi…

Chief Investment Officer — Talya Nevo-Hacohen: The Chief Investment Officer is retiring with a named internal successor and a structured consulting transition plan, indicating an orderly succession rather than a sudden loss of leadership.

Results of Operations and Financial Condition. On February 19, 2025, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended December 31, 2024. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnish…

Director — Clifton J. Porter II: A director is voluntarily choosing not to stand for reelection to pursue a new executive role, which is a standard board turnover event without indication of conflict or distress.

Results of Operations and Financial Condition. On October 31, 2024, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended September 30, 2024. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnish…

Results of Operations and Financial Condition. On August 7, 2024, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended June 30, 2024. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnished here…

Results of Operations and Financial Condition. On May 8, 2024, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended March 31, 2024. The press release refers to the Reconciliations of Non-GAAP Financial Measures that is available on the Investors section of Sabra’s website, free of charge, at www.sabrahealth.com. The text of the press release and the Reconciliations of Non-GAAP Financial Measures are furnished herewi…